In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376
To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: Pediatric Cardiology, 2014, vol. 35, no. 1, p. 71-76
|
Mémoire de bachelor : Haute Ecole de Santé de Fribourg, 2018.
L’incontinence urinaire est un problème de santé, touchant majoritairement des personnes âgées et dont sa prévalence ne cesse d’augmenter (Curaviva, 2014). Des interventions issues des données probantes ayant pour but d’améliorer la qualité de vie des personnes touchées sont recommandées dans les guidelines depuis des années. Cependant, des lacunes importantes quant à leur mise...
|
In: Journal of Neurology, 2013, vol. 260, no. 2, p. 421-428
|
In: European Journal of Pediatrics, 2006, vol. 165, no. 2, p. 94-98
|
In: World Journal of Surgery, 2011, vol. 35, no. 2, p. 280-288
|
In: World Journal of Pediatrics, 2009, vol. 5, no. 1, p. 18-22
|
In: European Journal of Pediatrics, 2011, vol. 170, no. 9, p. 1111-1127
|
In: Supportive Care in Cancer, 2012, vol. 20, no. 1, p. 141-147
|